$1.55 9.9%
CDLX Stock Price vs. AI Score
Data gathered: April 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Cardlytics (CDLX)

Analysis generated April 4, 2025. Powered by Chat GPT.

Cardlytics, Inc. (CDLX) operates a purchase intelligence platform that helps marketers to understand consumer spending patterns. By partnering with financial institutions, Cardlytics provides insights from anonymized transaction data to deliver targeted marketing campaigns. This data-driven approach is designed to improve return on marketing investment for brands and increase customer engagement for financial institutions. Despite its innovative model, Cardlytics faces significant challenges in maintaining growth and profitability.

Read full AI stock Analysis

Stock Alerts - Cardlytics (CDLX)

company logo Cardlytics | April 15
Price is up by 7.1% in the last 24h.
company logo Cardlytics | April 10
Price is down by -7.7% in the last 24h.
company logo Cardlytics | April 9
Price is up by 5.3% in the last 24h.
company logo Cardlytics | April 8
Price is up by 5.5% in the last 24h.

About Cardlytics

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom.


Cardlytics
Price $1.55
Target Price Sign up
Volume 525,750
Market Cap $74M
Year Range $1.23 - $6.9
Dividend Yield 0%
Analyst Rating 0% buy
Industry Marketing & Advertising

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2467M164M-97M-145M-142M-0.150
Q2 '2470M37M33M-4.3M-9.3M-0.150
Q1 '2468M35M33M-24M-17M-0.090
Q4 '2389M105M-16M-101M-93M0.140
Q3 '2379M36M43M-24M-17M0.010

Insider Transactions View All

Lynton Nicholas Hollmeyer filed to sell 101,740 shares at $1.8.
April 3 '25
DeSieno Alexis filed to sell 147,300 shares at $1.8.
April 3 '25
Gupta Amit filed to sell 371,080 shares at $1.8.
April 3 '25
Gupta Amit filed to sell 364,072 shares at $3.2.
February 19 '25
DeSieno Alexis filed to sell 140,948 shares at $3.4.
February 18 '25

What is the Market Cap of Cardlytics?

The Market Cap of Cardlytics is $74M.

What is the current stock price of Cardlytics?

Currently, the price of one share of Cardlytics stock is $1.55.

How can I analyze the CDLX stock price chart for investment decisions?

The CDLX stock price chart above provides a comprehensive visual representation of Cardlytics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cardlytics shares. Our platform offers an up-to-date CDLX stock price chart, along with technical data analysis and alternative data insights.

Does CDLX offer dividends to its shareholders?

As of our latest update, Cardlytics (CDLX) does not offer dividends to its shareholders. Investors interested in Cardlytics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Cardlytics?

Some of the similar stocks of Cardlytics are Groupon, QuinStreet, Omnicom Group, Trade Desk, and Semrush.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.